OBESITY AS A RISK FACTOR FOR HIGHER FREQUENCY OF MACROSCOPIC INVASION OF PAPILLARY THYROID CARCINOMA
Authors:
- Andrii DinetsADAndrii Dinets
- Igor LurinILIgor Lurin
- Maksym GorobeikoMGMaksym Gorobeiko
- Victoria HoperiaVHVictoria Hoperia
- Karim AbdallaKAKarim Abdalla
- Andrii LovinALAndrii Lovin
- А.в. ДінецьАДА.в. Дінець
- І.а. ЛурінІЛІ.а. Лурін
- М.б. ГоробейкоМГМ.б. Горобейко
- В.г. ХоперіяВХВ.г. Хоперія
- А.в. ЛьовінАЛА.в. Льовін
Open Access
- 4 November 2025
- journal article
- Published by Poltava State Medical University (PSMU) in Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії
- Vol. 25 (3) , 30-34
Abstract
Background. Papillary thyroid carcinoma (PTC) is a malignant neoplasm originating from thyroid follicular cells and accounts for up to 80% of all thyroid cancer cases. It is the most common endocrine malignancy both in Ukraine and worldwide. Aim. The aim of this study was to investigate and evaluate the macroscopic invasive features of papillary thyroid carcinoma in overweight and obese patients, and to compare them with those in patients of normal weight. Participants and Methods: A total of 91 patients diagnosed with papillary thyroid carcinoma who underwent surgical treatment at Verum Expert Clinic (Kyiv, Ukraine) were included in the study. The cohort was divided based on body mass index (BMI): 26 patients with normal weight (BMI < 23.9 kg/m²); 45 patients with overweight (BMI 24.0–29.9 kg/m²); 20 patients with obesity (BMI ≥ 30.0 kg/m²). Clinical and pathohistological parameters were retrieved from archived medical records. All patients underwent standard preoperative evaluation, including thyroid hormone testing, clinical chemistry, and ionized calcium analysis. Results. A statistically significant difference in the frequency of macroscopic invasion into surrounding thyroid structures was observed across the BMI-based groups. Macroscopic invasion was identified in 6 patients with obesity (30%), 1 patient with overweight (2.2%), and in 4 patients with normal weight (15%) (p = 0.041). Further statistical analysis confirmed a significantly higher rate of macroscopic tumor spread in patients with obesity compared to other BMI categories (p = 0.019), suggesting a possible link between increased body weight and more aggressive local tumor behavior. Conclusions. Patients with papillary thyroid carcinoma and obesity demonstrate a higher incidence of macroscopic invasion into adjacent tissues, which may reflect a more aggressive biological behavior of the tumor. These findings highlight the importance of preoperative risk assessment in overweight and obese patients, the potential need for more radical surgical intervention (e.g., extended neck dissection), and careful long-term follow-up due to the increased risk of disease progression.Keywords
This publication has 34 references indexed in Scilit:
- ASAP1 Promotes Epithelial to Mesenchymal Transition by Activating the TGFβ Pathway in Papillary Thyroid CancerCancer Medicine, 2025
- Metformin as a promising therapeutic agent for papillary thyroid cancer: Mechanisms of antitumor and pro-apoptotic activityTranslational Oncology, 2025
- Insulin resistance factors associated with differentiated thyroid carcinoma and malignant cytology: serum thyroxine as an associated factorAnnals of Medicine, 2025
- The Interaction Between Sex and Thyroid Cancer Development and ManagementEndocrinology and Metabolism Clinics of North America, 2025
- Impact of microscopic margin involvement on recurrence of papillary thyroid carcinomaEuropean Journal of Surgical Oncology, 2025
- Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐ 1RA ‐based weight‐loss therapiesDiabetes, Obesity and Metabolism, 2025
- Thyroid cancerThe Lancet, 2023
- Risk factors for difficult thyroidectomy and postoperative morbidity do not match: retrospective study from an endocrine surgery academic referral centreUpdates in Surgery, 2022
- Papillary thyroid microcarcinoma: optimal management versus overtreatmentCurrent Opinion in Oncology, 2020
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016